Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
Yeonjung Yoon(Yonsei University), Jin Sook Yoon(Yonsei University)
Cited by 2
Related Papers
Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model
|PLoS ONE|2020|17
Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves’ Orbitopathy
|Investigative Ophthalmology & Visual Science|2020|12
Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves’ Orbitopathy
|Investigative Ophthalmology & Visual Science|2022|11
The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves’ Orbitopathy
|Investigative Ophthalmology & Visual Science|2023|10